• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIOMED GMBH & CO. MEDIZINTECHNIK KG FLUENCY PLUS VASCULAR STENT GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIOMED GMBH & CO. MEDIZINTECHNIK KG FLUENCY PLUS VASCULAR STENT GRAFT Back to Search Results
Catalog Number FVL14120
Device Problems Positioning Failure (1158); Misfire (2532)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/06/2022
Event Type  malfunction  
Manufacturer Narrative
The catalog number identified in section d4 has not been cleared in the us but is similar to the fluency plus endovascular stent graft products that are cleared in the us.The pro code and 510 k number for the fluency plus endovascular stent graft products are identified in d2 and g4.As the lot number for the device was provided, a review of the device history records is currently being performed.The device has been returned to the manufacturer for evaluation.The investigation of the reported event is currently underway.
 
Event Description
It was reported that during stent graft placement procedure for iliac via over the upper arm arteries, stent allegedly could not be deployed.The procedure was completed using another device.There was no reported patient injury.
 
Event Description
It was reported that during stent graft placement procedure for iliac via over the upper arm arteries, stent allegedly could not be deployed.The procedure was completed using another device.There was no reported patient injury.
 
Manufacturer Narrative
H10: the catalog number identified in section d4 has not been cleared in the us but is similar to the fluency plus endovascular stent graft products that are cleared in the us.The pro code and 510 k number for the fluency plus endovascular stent graft products are identified in d2 and g4.H10: manufacturing review: the lot history records of this lot were reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met the specification prior to shipment.Based on the information available it is not reasonably suggested that a manufacturing process may have caused or contributed to the reported issue.Investigation summary: a delivery system of a 13,5 x 120mm stent graft was returned for evaluation.The stent graft was partially deployed upon sample receipt and the outer sheath was elongated, which is an indication for high deployment forces applied to the system.The system was reported to be flushed prior to use.However, no introducer sheath was used for the procedure.In addition, the devices were used during a aaa procedure and the intended placement site was reported to be kinked.Based on information provided and the evaluation of the sample returned, it is confirmed that the stent graft could not be deployed completely.A definite root cause for the reported issue could not be determined.The reported use of the device during a aaa procedure represents an off label use of the device.Labeling review: the relevant labeling of this product was reviewed.Regarding preparation of the device the instructions for use states that "prior to loading the vascular system over a guide wire, both ports must be flushed with sterile saline.Flushing these lumens will also facilitate stent graft deployment." regarding the anatomy of the placement site the instructions for use states: "prior to stent graft deployment, ensure that the proximal stent graft end is positioned in a straight section of the lumen to reduce the risk of increased deployment forces and possible failure to deploy." regarding accessories the instructions for use states: "a super stiff guide wire (0.035 in.) is advanced from a femoral artery puncture site.Use an introducer sheath for the implant procedure" and the packaging pictograms indicate an introducer size of 9f and a 0.035" guidewire.The reported use of the device during a aaa procedure represents an off label use of the device.Based on the instructions for use supplied with this product, the fluency plus vascular stent graft is intended to be used for treatment of a residual stenosis, a dissection, detached arteriosclerotic plaque material and luminal obstruction following balloon dilatation, occlusion and restenosis or reocclusion in the femoral and iliac arteries.H10: d4 (expiry date: 07/2025), g3.H11: h6 (result, conclusion).H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FLUENCY PLUS VASCULAR STENT GRAFT
Type of Device
VASCULAR STENT GRAFT
Manufacturer (Section D)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG
wachhausstr. 6
karlsruhe 76227
GM  76227
Manufacturer (Section G)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG
wachhausstr. 6
karlsruhe 76227
GM   76227
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key16360350
MDR Text Key309496371
Report Number9681442-2023-00026
Device Sequence Number1
Product Code PFV
UDI-Device Identifier00801741145377
UDI-Public(01)00801741145377
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P130029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/02/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberFVL14120
Device Lot NumberANGU2388
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/04/2023
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/16/2023
Initial Date FDA Received02/13/2023
Supplement Dates Manufacturer Received03/02/2023
Supplement Dates FDA Received03/18/2023
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-